Healthcare -
Biotechnology - NASDAQ - US
$ 21.93
1.2 %
$ 3.16 B
Market Cap
-7.95
P/E
DNLI - DEPRECIATION & AMORTIZATION
Depreciation & Amortization DNLI - Denali Therapeutics Inc.
16.7 M
LAST VALUE
39.52%
2 YEAR CAGR
17.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR